| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.035 | 33.442 | 36.187 | 24.525 | 31.095 | 22.241 | 36.528 | 20.431 | 13.047 | - |
| Total Income - EUR | 10.215 | 33.610 | 37.203 | 24.618 | 31.145 | 24.126 | 36.533 | 20.432 | 13.089 | - |
| Total Expenses - EUR | 9.660 | 31.253 | 40.002 | 29.901 | 39.027 | 35.341 | 31.045 | 23.462 | 14.777 | - |
| Gross Profit/Loss - EUR | 555 | 2.357 | -2.800 | -5.283 | -7.882 | -11.215 | 5.487 | -3.030 | -1.687 | - |
| Net Profit/Loss - EUR | 249 | 1.349 | -3.461 | -5.528 | -8.193 | -11.441 | 4.392 | -3.713 | -1.775 | - |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - |
Check the financial reports for the company - Reb-Cri Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 504 | 0 | 0 | 90 | 89 | 87 | 85 | 561 | 474 | - |
| Current Assets | 13.160 | 24.485 | 24.443 | 21.159 | 19.268 | 11.845 | 9.867 | 8.248 | 11.193 | - |
| Inventories | 11.038 | 12.754 | 14.400 | 16.545 | 12.600 | 9.344 | 6.941 | 3.999 | 5.448 | - |
| Receivables | 2.030 | 11.504 | 9.972 | 4.203 | 4.371 | 2.239 | 2.459 | 3.498 | 4.395 | - |
| Cash | 91 | 226 | 72 | 411 | 2.297 | 262 | 467 | 751 | 1.350 | - |
| Shareholders Funds | -34.102 | -32.405 | -35.318 | -33.858 | -41.395 | -52.052 | -46.506 | -50.364 | -51.986 | - |
| Social Capital | 45 | 45 | 44 | 6.383 | 6.259 | 6.141 | 6.004 | 6.023 | 6.005 | - |
| Debts | 47.765 | 56.890 | 59.761 | 55.107 | 60.752 | 63.983 | 56.458 | 59.173 | 63.653 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Reb-Cri Med Srl